Login / Signup

Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study.

Reineke A SchootJulia C ChisholmMichela CasanovaVeronique Minard ColinDidier FrappazAlison L CameronBeatrice CoppadoroIlaria ZanettiDaniel OrbachAnna KelseyTimothy RogersCecile GuizaniMarkus ElzeMyriam Ben-ArushKieran McHughRick Robert van RijnSima FermanSoledad Gallego MelconAndrea C FerrariMeriel JenneyGianni BisognoJohannes Hendrikus Maria Merks
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Outcome remains poor for patients with metastatic RMS and multiple ORFs. Because of the design of the studies, it was not possible to determine whether the intensive induction regimen and/or the addition of maintenance treatment resulted in apparent improvement of outcome compared with historical cohorts. Further studies, with novel treatment approaches are urgently needed, to improve outcome for the group of patients with adverse prognostic factors.
Keyphrases
  • prognostic factors
  • small cell lung cancer
  • squamous cell carcinoma
  • computed tomography
  • radiation therapy
  • rectal cancer
  • replacement therapy
  • case control
  • adverse drug